Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/13/2024 | RENAISSANCE TECHNOLOGIES LLC | 542,663 | $912,000 | -1.31% | 3.80% |
05/10/2024 | VANGUARD GROUP INC | 374,251 | $628,742 | 0.00% | 2.62% |
05/10/2024 | DIMENSIONAL FUND ADVISORS LP | 357,615 | $600,793 | -2.27% | 2.50% |
05/15/2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $481,580 | 0.00% | 2.00% |
05/10/2024 | ACADIAN ASSET MANAGEMENT LLC | 188,164 | $315,000 | 0.00% | 1.32% |
05/10/2024 | BLACKROCK INC. | 110,564 | $185,748 | -0.38% | 0.77% |
05/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 84,522 | $142,019 | -0.88% | 0.59% |
04/25/2024 | BANK OF NEW YORK MELLON CORP | 75,268 | $126,450 | 0.00% | 0.53% |
05/15/2024 | CITADEL ADVISORS LLC | 38,100 | $64,008 | -6.16% | 0.27% |
05/15/2024 | STATE STREET CORP | 33,700 | $56,616 | -15.31% | 0.24% |
05/15/2024 | TWO SIGMA INVESTMENTS, LP | 32,430 | $54,482 | -1.82% | 0.23% |
05/15/2024 | TWO SIGMA ADVISERS, LP | 23,000 | $38,640 | -1.71% | 0.16% |
05/14/2024 | NORTHERN TRUST CORP | 16,338 | $27,448 | -10.18% | 0.11% |
05/15/2024 | CRESSET ASSET MANAGEMENT, LLC | 12,025 | $20,202 | 0.00% | 0.08% |
05/15/2024 | MORGAN STANLEY | 11,274 | $18,940 | 0.00% | 0.08% |
05/15/2024 | TOWER RESEARCH CAPITAL LLC (TRC) | 5,747 | $9,655 | 2.11% | 0.04% |
05/15/2024 | CITADEL ADVISORS LLC | 3,622 | $6,085 | 2.46% | 0.03% |
04/22/2024 | OAKWORTH CAPITAL, INC. | 3,052 | $5,127 | 0.00% | 0.02% |
05/13/2024 | UBS GROUP AG | 1,793 | $3,012 | 1,530.00% | 0.01% |
05/15/2024 | CITADEL ADVISORS LLC | 200 | $336 | -96.49% | 0.00% |
05/10/2024 | ADVISOR GROUP HOLDINGS, INC. | 100 | $168 | 100.00% | 0.00% |
05/10/2024 | WELLS FARGO & COMPANY/MN | 65 | $109 | 3.17% | 0.00% |
05/10/2024 | JPMORGAN CHASE & CO | 20 | $34 | 66.67% | 0.00% |
05/03/2024 | HUNTINGTON NATIONAL BANK | 1 | $2 | 0.00% | 0.00% |
05/15/2024 | BANK OF AMERICA CORP /DE/ | 0 | $0 | -100.00% | 0.00% |
04/11/2024 | WILEY BROS.-AINTREE CAPITAL, LLC | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 43 institutional investors and hedge funds held shares of Cumberland Pharmaceuticals Inc.. The most heavily invested institutionals were:
RENAISSANCE TECHNOLOGIES LLC: 542,663
VANGUARD GROUP INC: 374,251
DIMENSIONAL FUND ADVISORS LP: 357,615
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 286,655
ACADIAN ASSET MANAGEMENT LLC: 188,164
BlackRock Inc.: 110,564
A. 15.13% of Cumberland Pharmaceuticals Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 2.89 M shares in the last 24 months. This purchase volume represents approximately $4.43 M in transactions.